New innovations in the pharmaceutical and biotech industry must pass through trials to find out the effectiveness and side effects. The innovation is given a Go, if the benefits way outweighs the side effects, if not it is taken back to the lab for more research.
While Food biotechnology may be the solution to food insecurity in Africa through GMOs, Africa must research, develop, produce the GMOs themselves. African nations must understand the innovation enough to be able to decide whether it should be adopted or modified to benefit their citizens.
The health and well-being of Africans cannot be left in the hands of profit-at-all-cost multinationals who may want to use Africans as guinea pigs for new innovations. As much as trials are a big part of research and development (R&D), African countries must carry it out themselves for themselves.
It is time for African countries to build their own biotech industry, not only because the future will depend on it, but mainly because multinationals like Monsanto cannot be trusted as investigation has shown that the food biotech company based in the United State has endangered people’s health just for profit. The Guardian reported that Monsanto sold banned chemicals for years despite known health risks, archives reveal.
It was reported that Monsanto continued to produce and sell toxic industrial chemicals known as PCBs for eight years after learning that they posed hazards to public health and the environment, according to legal analysis of documents put online in a vast searchable archive.
According to The Guardian, Polychlorinated biphenyls (PCBs) are long-lived pollutants that were mass-produced by Monsanto between 1935 and 1977 for use as coolants and lubricators in electrical equipment such as transformers and capacitors.
By 1979, they had been completely banned in the US and elsewhere, after a weight of evidence linking them to health ailments that ranged from chloracne and Yusho (rice oil disease) to cancer, and to environmental harm.
Yet a decade earlier, one Monsanto pollution abatement plan in the archive from October 1969, singled out by Sherman, suggests that Monsanto was even then aware of the risks posed by PCB use.
More than 20,000 internal memos, minuted meetings, letters and other documents have been published in the new archive revealed, many for the first time.
Most were obtained from legal discovery and access to documents requests digitized by the Poison Papers Project, which was launched by the Bioscience Resource Project and the Center for Media and Democracy. Chiron Return contributed some documents to the library.
Bill Sherman, the assistant attorney general for the US state of Washington – which is suing Monsanto for PCB clean-up costs potentially worth billions of dollars – said the archive contained damning evidence the state had previously been unaware of.
He told the Guardian: “If authentic, these records confirm that Monsanto knew that their PCBs were harmful and pervasive in the environment, and kept selling them in spite of that fact. They knew the dangers, but hid them from the public in order to profit.”
Monsanto’s vice president of global strategy, Scott Partridge, did not dispute the authenticity of the documents revealed in the online cache but denied any impropriety.
He told the Guardian: “More than 40 years ago, the former Monsanto voluntarily stopped production and sale of PCBs prior to any federal requirement to do so. At the time Monsanto manufactured PCBs, they were a legal and approved product used in many useful applications. Monsanto has no liability for pollution caused by those who used or discharged PCBs into the environment.”